podcast
details
.com
Print
Share
Look for any podcast host, guest or anyone
Search
Showing episodes and shows of
FNLA
Shows
Medication Talk
Antidepressant Insights
Listen in as our expert panel discusses practical considerations for starting and optimizing antidepressants for treating depression and anxiety. You’ll listen to panelists cover various aspects of antidepressant use, such as serotonin syndrome, QT prolongation, and weight gain concerns.Special guest(s):Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP Director of Pharmacy and Residency Programs, New York State Office of Mental Health State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences Sarah E. Grady, PharmD, BCPS, BCPPProfessor, Drake University College of Pharmacy and Health SciencesClinical Pharmacist, Inpatient Behavioral Health Unit, Broadl...
2025-07-01
38 min
Medication Talk
Meds for Alzheimer Dementia
Listen in as our expert panel discusses medications for the treatment of Alzheimer dementia. They'll review the risks and benefits of cholinesterase inhibitors, memantine, and the anti-amyloid monoclonal antibodies. And you’ll hear strategies for managing behavioral and psychological symptoms of dementia. Special guests:Tatyana Gurvich, PharmD, BCGP, APhAssociate Professor of Clinical PharmacyMann USC School of PharmacyUCI Senior Health CenterCandace Pierce, DNP, RN, CNE, COINurse Educator, Nurse Planner, and Healthcare Leader, Colibri HealthcareDarlene Moyer, MD, FAAFPAssociate Director, HonorHealth Family Medicine Residency ProgramAssociate Professor of Clinical Practice – SOMME – Arizona State UniversityClinical Associate Professor – University of Arizona College of Medicine...
2025-06-01
35 min
Medication Talk
Medications for Opioid Use Disorder
Listen in as our expert panel discusses medications for management of opioid use disorder. They’ll review strategies to optimize buprenorphine use and clarify the role of methadone and naltrexone.Special guest:Tyler J. Varisco, PharmD, PhDUniversity of Houston College of Pharmacy Assistant Professor, Department of Pharmaceutical Health Outcomes and PolicyAssistant Director, The PREMIER CenterYou’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Associate Professor of Family Medicine for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program at the Uni...
2025-05-01
37 min
Medication Talk
Bronchitis and Pneumonia Treatment
In this episode, listen in as our expert panel digs into identifying and treating acute bronchitis and community-acquired pneumonia. They’ll discuss when antibiotics are appropriate, which antibiotics to use, and other management tips.You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Program Director for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program and Clinical Associate Professor at the University of South Carolina School of Medicine, GreenvilleAndrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Fam...
2025-03-01
34 min
Medication Talk
Asthma and COPD Treatment
Special guest Lori A. Wilken, PharmD, FCCP, BCACP, NCTTP, AE-C, Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Illinois, Chicago, joins us to talkabout Asthma and COPD treatment.Listen in as we discuss answers to your big questions about treatment of asthma and COPD. You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine GreenvilleAndrea Darby Stewart, MD, Associate Direc...
2024-10-01
35 min
Medication Talk
Precepting: Helping Learners Succeed
In this episode, listen in as our expert panelists discuss tips for creating successful learning experiences for students and residents. We’ll review various teaching tools and summarize strategies for incorporating learners into your practice. We’ll also discuss different approaches for providing meaningful feedback and managing challenging situations with learners.Our panel for this conversation includes: Andrea Darby Stewart, MD; Associate Director, Honor Health Family Medicine Residency Program; Clinical Professor of Family, Community & Occupational Medicine, University of Arizona College of Medicine – PhoenixMary Franks, MSN, APRN-FPA, FNP-C; Nurse Planner, NetCE; Adjunct Professor, Bradley University; Nurse Practitioner, Carle He...
2024-09-01
47 min
Lipid Insights
S5E1: A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice
Alan Brown, MD, FNLA talks with Christie Ballantyne, MD, FNLA about the publication of "A Focused Update to the 2019 NLA Scientific Statement On The Use of Lp(a) in Clinical Practice"
2024-05-03
31 min
Medication Talk
Managing Chronic Coronary Disease
Special guest Dave L. Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CDCES, CLS, the Nancy L. and Ronald H. McFarlane Professor of Pharmacy and Chair of the Department of Pharmacotherapy & Outcomes Science at the Virginia Commonwealth University School of Pharmacy, joins us to talk about chronic coronary disease.Listen in as he discusses the management of chronic coronary disease with a focus on the new American College of Cardiology/American Heart Association guidelines.You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Anthony A. Donato, Jr...
2023-11-01
33 min
Obesity: A Disease
Episode 87: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 2 of 3
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-08-28
18 min
Obesity: A Disease
Episode 87: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 2 of 3
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-08-28
18 min
Obesity: A Disease
Episode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-08-07
17 min
Obesity: A Disease
Episode 85: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk with Dr. Bindlish, Part 1 of 3
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-08-07
17 min
Lipid Insights
S4E2: Nutrition Interventions for Adults with Dyslipidemia
Alan Brown, MD, FNLA talks with Carol F. Kirkpatrick, PhD, MPH, RDN, CLS, FNLA and Kevin C Maki, PhD, CLS, FNLA, FTOS, FACN to discuss Nutrition Interventions for Adults with Dyslipidemia.
2023-07-31
36 min
Obesity: A Disease
Episode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health...
2023-05-18
16 min
Obesity: A Disease
Episode 83: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 3 of 3
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health...
2023-05-18
16 min
Obesity: A Disease
Episode 81: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 2 of 3
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-04-26
15 min
Obesity: A Disease
Episode 81: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk, Part 2 of 3
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in Obesity Pillars, for which Dr. Lowe-Clayton was a co-author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-04-26
15 min
Obesity: A Disease
Episode 78: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-03-24
21 min
Obesity: A Disease
Episode 78: Article Review: Obesity, Diabetes Mellitus, and Cardiometabolic Risk
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Tiffany Lowe-Clayton, DO. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Lowe-Clayton was a co- author. Obesity Pillars is the official Gold Open Access journal of the Obesity Medicine Association, available exclusively online. In our article review podcasts, we carefully select articles from the latest version of Obesity Pillars, which is devoted to the publication of clinical and evidence-based research for physicians, nurse practitioners, physician assistants and other health care...
2023-03-24
21 min
Obesity: A Disease
Episode 73: Article Reviews: Clinical Practice Statements for the Management of Obesity – Nutrition and Physical Activity, Part 2 of 2: Body Composition
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category. In our article review podcasts, we have carefully...
2022-12-16
20 min
Obesity: A Disease
Episode 73: Article Reviews: Clinical Practice Statements for the Management of Obesity - Nutrition and Physical Activity, Part 2 of 2: Body Composition
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category. In our article review podcasts, we have carefully...
2022-12-16
20 min
Obesity: A Disease
Episode 72: Article Reviews: Clinical Practice Statements for the Management of Obesity – Nutrition and Physical Activity, Part 1 of 2: Effective Patient Documentation; Electronic Medical Records (EMR’s) and Energy Expenditure
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category. In our article review podcasts, we have carefully...
2022-12-15
25 min
Obesity: A Disease
Episode 72: Article Reviews: Clinical Practice Statements for the Management of Obesity - Nutrition and Physical Activity, Part 1 of 2: Effective Patient Documentation; Electronic Medical Records (EMR's) and Energy Expenditure
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA about the Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) for which she was first author, titled 'Nutrition and Physical Activity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Topics include personal history documentation; laboratory procedures; components of energy expenditure; non-exercise activity thermogenesis (NEAT); accurately assessing and understanding body composition; body fat cut-off levels and the inclusion of a "pre-obesity" category. In our article review podcasts, we have carefully...
2022-12-15
25 min
Lipid Insights
S3E2: Statin Underuse Persistence
Alan Brown, MD, FNLA talks with Mary Katherine Cheeley, PharmD, FNLA about the persistence of statin underuse i practice.
2022-12-05
38 min
Obesity: A Disease
Episode 71: Article Reviews: Clinical Practice Statements for the Management of Obesity – Cancer and Obesity; Part 2 of 2
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the management and care of patients with obesity following a cancer diagnosis; the need for aggressive treatment of obesity using behavioral, medical and surgical strategies; the benefits of weight loss in cancer patients with obesity; and the devastating...
2022-09-09
18 min
Obesity: A Disease
Episode 71: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Part 2 of 2
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the management and care of patients with obesity following a cancer diagnosis; the need for aggressive treatment of obesity using behavioral, medical and surgical strategies; the benefits of weight loss in cancer patients with obesity; and the devastating...
2022-09-09
18 min
Obesity: A Disease
Episode 70: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Part 1 of 2
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...
2022-09-09
20 min
Obesity: A Disease
Episode 70: Article Reviews: Clinical Practice Statements for the Management of Obesity – Cancer and Obesity; Part 1 of 2
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...
2022-09-09
20 min
Obesity: A Disease
Episode 69: Article Reviews: Clinical Practice Statements for the Management of Obesity - Cancer and Obesity; Full Podcast
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...
2022-09-08
32 min
Obesity: A Disease
Episode 69: Article Reviews: Clinical Practice Statements for the Management of Obesity – Cancer and Obesity; Full Podcast
OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Ethan Lazarus, MD, FOMA, AMA Delegate about the Obesity Medicine Association (OMA) Clinical Practice Statement for which he was first author, titled 'Cancer and Obesity'. The CPS serves as a flexible guide for providers seeking to create or improve an obesity medicine program. Today's topics include the complex relationship between cancer and obesity; how the steep decline of nicotine use over the past 30 years can inform us regarding possibilities for obesity management and care; and the nature of fat as a metabolically, hormonally active...
2022-09-08
32 min
Medication Talk
Statin Intolerance
TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Joseph Saseen, PharmD, FCCP, FNLA, Associate Dean for Clinical Affairs, Professor, Department of Clinical Pharmacy and Professor, Department of Family Medicine from the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus about managing statin intolerance. Listen in as they discuss how to evaluate statin-associated muscle pain...and review strategies to help patients take a statin successfully. You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:Andrea Darby Stewart, MD, Associ...
2022-09-01
32 min
Obesity: A Disease
Episode 60: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Part 3 of 3: Telehealth
This episode is a segment focusing on obesity Telehealth services from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview with Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted...
2022-04-06
26 min
Obesity: A Disease
Episode 59: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Part 2 of 3:SOPs
This episode is a segment focusing on SOPs from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview with Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted to the publication of...
2022-04-06
06 min
Obesity: A Disease
Episode 58: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Part 1 of 3: Bias
This episode is a segment focusing on weight bias Bias from OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interview with Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted...
2022-04-06
09 min
Obesity: A Disease
Episode 57: Article Reviews: Obesity Definition, Diagnosis, Bias, Standard Operating Procedures (SOPs), and Telehealth; Full Podcast
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Angela K. Fitch MD, FACP, FOMA on the article: Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022 on which Dr. Fitch was first author. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Pillars, which is the official Gold Open Access online-only journal of the Obesity Medicine Association and is devoted to the publication of clinical and evidence-based research for...
2022-04-05
35 min
South African Border Wars
Episode 48 – Russian specialists set up anti-aircraft missiles and Special Forces ops accelerate across the cutline
The Russians were increasing their support for the MPLA in Luanda and one of those who arrived was Vladimir Vasilievich Kostrachenkov. He helped establish the Pechora Anti-Aircraft system between 1979 and 1981 in the south of Angola and published some of his thoughts in a book called Bush War, the Road to Cuito Cuanavale. While most of this book is about the major battles that took place later around Cuito, Kostrachenkov’s explanation of what happened in the south in the very 80s is important for us at this juncture. It was his second tour of duty of Angola – his first was...
2022-02-27
23 min
Obesity: A Disease
Episode 46: Article Reviews: Determinants of Weight Loss Maintenance
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC and Sarah Wells, MD discuss a recent article about the determinants of weight loss maintenance. Topics covered include what determinants were found to be positively predictive in weight loss maintenance, which determinants are non-significant for weight loss maintenance, and how to translate this article into clinical application. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is a comprehensive review of obesity medicine that...
2021-09-03
13 min
Obesity: A Disease
Episode 44: Article Reviews: Patient Assisted Virtual Physical
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Carolynn Francavilla, MD, FOMA to discuss a recent article on virtual physicals using telehealth. Topics covered include: Individualizing the telehealth physical exam, limitations and opportunities of the telehealth exam, and challenges for prescribing anti-obesity medications by telehealth. To access other resources from the clinical leader in Obesity Medicine, visit www.obesitymedicine.org. Episode Guests Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Carolynn Francavilla, MD, FOMA Resources Mentioned The Telehealth Ten...
2021-08-04
14 min
Obesity: A Disease
Episode 42: Article Reviews: Safety and Effectiveness of Longer-Term Phentermine Use
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Mahtab Ahmed, MD, FOMA, Dipl. ABOM about a recent article on the safety and effectiveness of longer-term Phentermine use. Topics covered include risks and benefits of prescribing Phentermine longer than 12 weeks, the impact of study results only including low cardiovascular disease risk patients and being a retrospective study, and the role of local regulations in prescribing. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which...
2021-06-30
17 min
South African Border Wars
Episode 18 – The Battle of Ebo - the first major defeat for the SADF during Operation Savannah
This is episode 18 and folks back home were in for a bit of a shock. The invasion of Angola by the SADF during Operation Savannah had been an exercise in support of both Unita and the FNLA – but the government had said that the South Africans were merely technical support. The reality was hundreds of SADF troops were directly involved in the fighting – and had fought all the way to south of the capital Luanda. This was almost a thousand kilometers inside Angola. As we heard last episode, by the end of November a group of liaison officers and...
2021-06-28
19 min
South African Border Wars
Episode 17 – The SAS Steyn’s role in the remarkable evacuation from the beach at Ambrizette
This is episode 17 and we’re approaching the end of Operation Savannah which had started out so well but was rapidly turning into a strategic nightmare for the South Africans. One of the fastest mechanised invasions since World War Two had resulted in the SADF now deep into Angola – and in the case of Brigadier Roos who was a liaison officer based in Ambriz with the FNLA – he was cut off on the coast to the north of the capital Luanda. IT was mid-November 1975 and the MPLA and Cubans were starting to move determined to rid the co...
2021-06-21
19 min
South African Border Wars
Episode 16 – Luanda’s “Death Road” leaves the FNLA in tatters and the CIA decides to up and off
This is episode 16 and we’re covering Operation Savannah which took place between October and December 1975. That was the invasion of southern Angola by the South African Defence Force in response to the outbreak of a civil war in the country involving the three main independence movements that had fought against Portuguese colonial rule. These were the MPLA, Unita and the FNLA. Our focus in this episode shifts in a while to the FNLA’s assault on the Capital Luanda. But first an update about the SADF. Brigadier Schoeman who was in char...
2021-06-14
18 min
Obesity: A Disease
Episode 40: Article Reviews: Long-Term Weight Loss in the Diabetes Prevention Program
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Laura Davisson, MD, MPH, FACP, to discuss a recent article on the comparison of Metformin and lifestyle intervention in diabetes prevention. Topics covered include the success of the intensive lifestyle intervention of the Diabetes Prevention Program, the difficulty many patients have with weight loss maintenance, and the consideration of prescribing Metformin for prediabetes. In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is a comprehensive...
2021-06-07
12 min
Obesity: A Disease
Episode 38: Article Reviews: Stress and Obesity
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Angela Golden, DNP, FNP-C, FAANP, to discuss a recent article on the connection between stress and obesity. Topics covered include clinical strategies for talking to patients about stress and obesity, the role of obesity bias and stigma in increasing patient stress, and how to manage hormones related to stress. Episode Guests Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Angela Golden, DNP, FNP-C, FAANP Resources Mentioned Tomiyama AJ: Stress and Obesity. Annu Rev...
2021-05-03
13 min
Obesity: A Disease
Episode 37: Clinical Conversations: Anti-Obesity Medicines Under Development
In this episode, obesity medicine specialist and OMA Clinical Education Director, Nicholas Pennings, DO, FOMA, Dipl. ABOM interviews Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, a highlighted speaker from Overcoming Obesity 2020 – Virtual, about new pharmaceutical agents in development to treat obesity. Topics covered include why anti-obesity medicines may be necessary in treatment, treatment targets and efficacy of newer pharmaceutical agents, role of combination medications in treatment, and a discussion about stigma and bias around anti-obesity medications. You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at ww...
2021-04-19
35 min
Obesity: A Disease
Episode 36: Clinical Conversations: Starting an Obesity Medicine Practice
In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Karli Burridge, PA-C, MMS, FOMA to discuss her experience in starting an obesity medicine practice. Topics covered include: practice components and structure to consider when starting a practice, general business start-up practices, payment, and practice models, and recommended standard operating procedures. To access other resources from the clinical leader in Obesity Medicine, visit: www.obesitymedicine.org. Episode Guests Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC Karli Burridge, PA-C, MMS, FOMA Resources Mentioned
2021-04-05
33 min
Taxi Brousse
Episode 20
Angelique – Lokassa Ya Mbongo (Congo)Petit précis sur les Congo.La république démocratique du Congo, parfois appelée Congo-Kinshasa du nom de sa capitale, anciennement État indépendant du Congo (1877-1908), Congo belge (1908-1960), république du Congo-Léopoldville (1960-1964), république démocratique du Congo (1964-1971) et Zaïre de 1971 à 1997, 97 c’est la fin du règne de Joseph-Désiré Mobutu.Son voisin, le Congo, parfois appelé Congo-Brazaville, était une colonie française. Qui porta aussi le nom de République congolaise de 1960 à 1965, république du Congo de 1965 à 1969 et de république populaire du Congo de 1969...
2019-11-24
00 min
Obesity: A Disease
Episode 3: Article Reviews: Progress and Challenges in Anti-Obesity Pharmacotherapy
Episode Description In our article review podcasts, we have carefully selected recent articles included in the latest version of the OMA Obesity Algorithm. We then discuss this new science with obesity experts. In this episode, Harold Bays, MD, FOMA, FTOS, FACC, FACE, FNLA, Dipl. ABOM interviews Larry Richardson, MD, MFOMA about a recent publication on progress and challenges in anti-obesity pharmacotherapy. Topics covered include: barriers to the use of anti-obesity medication, new, most promising agents being considered that may come to fruition, and dialoging about the resistance of combination therapy for treating obesity. To access other resources from the clinical l...
2019-08-05
10 min
iUniverse
Brian Scott Edwards, MD, FNLA, S. T. Byra and Leo Cauzillo
iUniverse Radio order of interviews for show: 3:00-4:00PM EST 1. “The Chronic Disease of Obesity: How Sponge Syndrome Causes Repeated Weight Gain”; by Brian Scott Edwards, MD, FNLA 2. “One and One Is One: The Beginning”; by S. T. Byra 3. “They are Not Alone: Mythology or History”; by Leo Cauzillo
2019-06-10
47 min
The Peter Attia Drive
Tom Dayspring, M.D., FACP, FNLA – Part V of V: Lp(a), inflammation, oxLDL, remnants, and more
In this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part V, Peter and Tom talk about inflammation, endothelial health, and oxidative stress as they pertain to cardiovascular disease, and our attempts to monitor them using biomarkers. They also discuss a couple of very important risk factors that too few people (and doctors) know about. Tom closes the five-part series with a tragic story about his good friend that is likely all-too-common for many practicing...
2018-10-19
1h 29
The Peter Attia Drive
Tom Dayspring, M.D., FACP, FNLA – Part IV of V: Statins, ezetimibe, PCSK9 inhibitors, niacin, cholesterol and the brain
In this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part IV, Peter and Tom review the history and current use of drugs to prevent cardiovascular disease. They also discuss why some drugs appear to be more effective than others, an in-depth conversation about niacin, cholesterol and brain health, and the futility of using CKs (creatinine kinase) and liver function tests to identify adverse effects in statins, to name a few topics in this episode.
2018-10-18
2h 00
The Peter Attia Drive
Tom Dayspring, M.D., FACP, FNLA – Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteins
In this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part III, Peter and Tom dig into HDL, why "reverse cholesterol transport" is a lot more nuanced than what most of us are taught, lipid transport, apolipoproteins, and more. In addition, this episode highlights the complexity of HDL and a discussion about the CETP inhibitor trials. We discuss: Reverse cholesterol transport [1:40]; Lipid transportation, apolipoproteins, VLDL, IDL, and LDL particles [11:00]; Remnant lipoproteins and...
2018-10-17
1h 04
The Peter Attia Drive
Tom Dayspring, M.D., FACP, FNLA – Part II of V: Lipid metrics, lipid measurements, and cholesterol regulation
In this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. In Part II, Tom provides a 101 on lipids and lipoproteins. Tom and Peter also discuss the history and techniques used to measure lipoproteins, and more. We discuss: Lipoprotein basics [1:30]; Gofman and the ultracentrifuge [5:15]; Lipoprotein structure, function, metabolism [6:45]; Lipoprotein and cholesterol measurement, and NMR technology [15:15]; LDL-C vs LDL-P and apoB [30:45]; Sterols and cholesterol synthesis [39:45]; and More. Learn more at www.PeterAttiaMD.com Connect with Peter on...
2018-10-16
1h 26
The Peter Attia Drive
Thomas Dayspring, M.D., FACP, FNLA – Part I of V: an introduction to lipidology
In this five-part series, Thomas Dayspring, M.D., FACP, FNLA, a world-renowned expert in lipidology, and one of Peter's most important clinical mentors, shares his wealth of knowledge on the subject of lipids. Part I serves as an introduction to Tom, his work, and an overview of lipid terminology. We discuss: Tom’s recent and remarkable physical transformation [6:30]; The moving stories behind Tom’s obsessions: firefighting, hockey, and, of course, lipids [20:30]; Tom’s medical background [39:30]; Producing some of the most accessible diagrams on lipids [50:00]; What are the different kinds of lipids, what do they do, and how ar...
2018-10-15
1h 14
Lipid Luminations
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.
2016-05-09
00 min
Vascular Medicine
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.
2016-05-09
00 min
Geriatrics
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.
2016-05-09
00 min
Focus on Heart Health
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
Host: Alan S. Brown, MD, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.
2016-05-09
00 min
Cardiology
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.
2016-05-09
00 min
Geriatrics
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.
2016-05-09
00 min
Cardiology
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA Host Dr. Alan Brown welcomes Joyce Ross, MSN, CRNP, FNLA, President-Elect of the National Lipid Association. Joyce serves as a consultative education specialist in cardiovascular risk intervention with the University of Pennsylvania Health System. Their discussion focuses on lipid management to reduce atherosclerotic cardiovascular disease (ASCVD) risk in elderly patient populations. Thhis interview was recorded live at the National Lipid Association in San Diego, California for the 2016 Spring Clinical Lipid Update.
2016-05-09
00 min
Lipid Luminations
The Lipidology Essentials: Making of a Specialty's Annual Summary
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Harold Bays, MD, FNLA Dr. Alan Brown welcomes Dr. Harold Bays, President of the Southeast Lipid Association and President of the Louisville Metabolic and Atherosclerotic Research Center in Louisville, KY. Dr. Bays led a novel educational effort to provide an annual summary of clinical lipidology to readers of the Journal of Clinical Lipidology. With insightful commentaries of value to lipidologists and generalists alike, the annual summary is expected to pave new ground in the ongoing effort to keep clinicians up to date with the field.
2016-04-18
00 min
Vascular Medicine
Updated NLA Recommendations for African American Patients
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA Host Dr. Alan Brown is joined by Dr. Keith C. Ferdinand, Professor at Tulane University School of Medicine in New Orleans, Louisiana. Dr. Ferdinand reviews the etiologies, diagnostic challenges, and management considerations for selective cardiac health issues prevalent in African American populations, from hypertension to coronary arterial calcium plaques to lipid levels. Supported by an Educational Grant from AstraZeneca.
2015-08-03
00 min
Lipid Luminations
Updated NLA Recommendations for African American Patients
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA Host Dr. Alan Brown is joined by Dr. Keith C. Ferdinand, Professor at Tulane University School of Medicine in New Orleans, Louisiana. Dr. Ferdinand reviews the etiologies, diagnostic challenges, and management considerations for selective cardiac health issues prevalent in African American populations, from hypertension to coronary arterial calcium plaques to lipid levels. Supported by an Educational Grant from AstraZeneca.
2015-08-03
00 min
Lipid Luminations
Dyslipidemia in The Elderly: How Old is "Too Old" to Treat?
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Joyce Ross, MSN, CRNP, CS, CLS, FNLA, FPCNA One of the most recurrent questions that cardiologists and lipidologists face in daily practice is how to best approach the elderly patient with dyslipidemia. Joining Dr. Alan Brown for special considerations in this population and guideline-based recommendations for management is Joyce Ross, certified registered nurse practitioner, clinical lipid specialist, and President-Elect of the National Lipid Association. Supported by an Educational Grant from AstraZeneca.
2015-07-27
00 min
Congo Live
James L Hope: Black Lives Matter - from Baltimore to the Congo
James L. Hope joins Congo Live! to discuss his time in the Congo and the current situation in Baltimore. He was also in the Congo in the 1960s and kept the tradition alive of supporting liberation movement on the African continent. We will also discuss current affairs in Baltimore. Bio: James L. Hope is the International Advisor of the African Scientific Institute (ASI). He first set foot on the African Continent in 1951 when his ship stopped in Alexandria, Egypt on its way to Beirut, Lebanon where he took up residence and attended school. Over the years Mr. Hope assisted in...
2015-05-04
00 min
Video Library
Roles of Non-HDL Cholesterol in Risk Assessment and Treatment
Host: Alan S. Brown, MD, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the clinical dogma once focused on targeting specific lipoproteins, clinicians are now trending toward using appropriate dosages of statins for lowering non-HDL cholesterol. What are the ramifications of this change in approach, and how does the NLA weigh in on recommendations for targets and goals? To address these and other questions, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center...
2014-09-16
00 min
Medical Research
Roles of Non-HDL Cholesterol in Risk Assessment and Treatment
Host: Alan S. Brown, MD, FACC, FAHA, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the clinical dogma once focused on targeting specific lipoproteins, clinicians are now trending toward using appropriate dosages of statins for lowering non-HDL cholesterol. What are the ramifications of this change in approach, and how does the NLA weigh in on recommendations for targets and goals? To address these and other questions, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for...
2014-09-16
00 min
Lipid Luminations
Roles of Non-HDL Cholesterol in Risk Assessment and Treatment
Host: Alan S. Brown, MD, FACC, FAHA, FNLA A paradigm shift in the management of lipid disorders has been witnessed of late based on evidence reviews by the AHA and the ACC. Where the clinical dogma once focused on targeting specific lipoproteins, clinicians are now trending toward using appropriate dosages of statins for lowering non-HDL cholesterol. What are the ramifications of this change in approach, and how does the NLA weigh in on recommendations for targets and goals? To address these and other questions, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for...
2014-09-16
00 min
Medical Research
Keys to the Latest NLA Recommendations for Dyslipidemia Treatments
Host: Alan S. Brown, MD, FACC, FAHA, FNLA What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA recommendations is Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Produced in partnership with
2014-09-09
00 min
Video Library
Keys to the Latest NLA Recommendations for Dyslipidemia Treatments
Host: Alan S. Brown, MD, FNLA What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA recommendations is Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Produced in partnership with
2014-09-09
00 min
Lipid Luminations
Keys to the Latest NLA Recommendations for Dyslipidemia Treatments
Host: Alan S. Brown, MD, FACC, FAHA, FNLA What's the evidence for LDL and other non-HDL targets for primary and secondary prevention of heart disease? What are the comparative benefits versus toxicities of all lipid-lowering medications in clinical use? Addressing these and other questions from the standpoing of recent NLA recommendations is Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Produced in partnership with
2014-09-09
00 min
Lipid Luminations
Management of the Patient With Triglycerides 200-499 mg/dl.
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Carl Orringer, MD, FACC, FNLA What are some of the causes of high triglycerides? What is the biggest health risk? And, for these patients, at what level is the risk greater for developing pancreatitis and coronary artery disease? Host Dr. Alan Brown welcomes Dr. Carl Orringer, Associate Professor of Medicine at the Cardiology Division, University of Miami Medical Center and Director of the Preventive Cardiovascular Medicine and LDL apheresis program. In this edition of Lipid Luminations, Dr. Orringer will discuss the management of the patients with triglycerides 200-499...
2014-08-26
00 min
Video Library
Management of the Patient With Triglycerides 200-499 mg/dl.
Host: Alan S. Brown, MD, FNLA Guest: Carl Orringer, MD, FACC, FNLA What are some of the causes of high triglycerides? What is the biggest health risk? And, for these patients, at what level is the risk greater for developing pancreatitis and coronary artery disease? Host Dr. Alan Brown welcomes Dr. Carl Orringer, Associate Professor of Medicine at the Cardiology Division, University of Miami Medical Center and Director of the Preventive Cardiovascular Medicine and LDL apheresis program. In this edition of Lipid Luminations, Dr. Orringer will discuss the management of the patients with triglycerides 200-499 mg/dl.
2014-08-26
00 min
Lipid Luminations
What is the Safety of Statins in Patients with Diabetes?
Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FACC, FAHA, FNLA At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Drs. Brown and Maki discuss the evidence of the relationship of statin use and risk of new onset of diabetes; as well as, the relationship of statin use and the possiblity of worsening glycemia in those patients who...
2014-05-13
00 min
Cardiology
What is the Safety of Statins in Patients with Diabetes?
Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FACC, FAHA, FNLA At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Drs. Brown and Maki discuss the evidence of the relationship of statin use and risk of new onset of diabetes; as well as, the relationship of statin use and the possiblity of worsening glycemia in those patients who...
2014-05-13
00 min
Cardiology
What is the Safety of Statins in Patients with Diabetes?
Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FACC, FAHA, FNLA At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Drs. Brown and Maki discuss the evidence of the relationship of statin use and risk of new onset of diabetes; as well as, the relationship of statin use and the possiblity of worsening glycemia in those patients who...
2014-05-13
00 min
Miscellaneous Topics
What is the Safety of Statins in Patients with Diabetes?
Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FNLA At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, Chicago, IL. Drs. Brown and Maki discuss the evidence of the relationship of statin use and risk of new onset of diabetes; as well as, the relationship of statin use and the possiblity of worsening glycemia in those patients who have diabetes...
2014-05-13
00 min
Lipid Luminations
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia
Guest: Carl Orringer, MD, FACC, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Matthew Ito, PharmD, FNLA Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American College of Cardiology/American Heart Association Guidelines, and those...
2014-05-08
00 min
Cardiology
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia
Guest: Carl Orringer, MD, FACC, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Matthew Ito, PharmD, FNLA Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American College of Cardiology/American Heart Association Guidelines, and those...
2014-05-08
00 min
Miscellaneous Topics
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia
Guest: Kevin C. Maki, PhD, FNLA, CLS Guest: Carl Orringer, MD, FACC, FNLA Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FNLA Guest: Matthew Ito, PharmD, FNLA Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American College of Cardiology/American Heart Association Guidelines, and those also released...
2014-05-08
00 min
Cardiology
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia
Guest: Carl Orringer, MD, FACC, FNLA Guest: Kevin C. Maki, PhD, FNLA, CLS Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Matthew Ito, PharmD, FNLA Host Dr. Alan Brown is joined by an expert panel to discuss the NLA's latest draft document that will serve as recommendations to clinicians for the management of patients with dyslipidemia. The National Lipid Association's goal was to harmonize guidelines among what has been presented in the past by the ATP panel, the American College of Cardiology/American Heart Association Guidelines, and those...
2014-05-08
00 min
Lipid Luminations
Obesity, Diabetes and the Metabolic Syndrome
Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or the "lipid triad" of elevated triglycerides, low HDL cholesterol and a predominance of small, dense LDL particles.
2013-02-25
00 min
Miscellaneous Topics
Obesity, Diabetes and the Metabolic Syndrome
Guest: Kevin C. Maki, PhD, FNLA, CLS Host: Alan S. Brown, MD, FNLA Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or the "lipid triad" of elevated triglycerides, low HDL cholesterol and a predominance of small, dense LDL particles.
2013-02-25
00 min
Endocrinology
Evolving Treatments: A Review of What’s in the Pipeline
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Harold Bays, MD, FNLA Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs. Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in Louisville...
2012-09-21
00 min
Miscellaneous Topics
Evolving Treatments: A Review of What’s in the Pipeline
Guest: Harold Bays, MD, FNLA Host: Alan S. Brown, MD, FNLA Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs. Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in ...
2012-09-21
00 min
Endocrinology
Evolving Treatments: A Review of What’s in the Pipeline
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Harold Bays, MD, FNLA Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs. Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in Louisville...
2012-09-21
00 min
Lipid Luminations
Evolving Treatments: A Review of What’s in the Pipeline
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Harold Bays, MD, FNLA Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs. Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in Louisville...
2012-09-21
00 min
Medical Research
Emerging HDL Therapies: What’s Next on the Clinical Research Horizon
Guest: Benjamin J. Ansell, MD, FACC, FACP, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Benjamin Ansell, MD, professor of medicine and cardiology at University of Califronia at Los Angeles, CA and co-director of the Cholesterol and Hypertension Management Program at UCLA. Dr. Ansell reviews the latest trials: dal-OUTCOMES and AIM-HIGH. Dr. Ansell will address the objectives and study designs of both studies and explain why the studies were stopped early. Drs. Brown and Ansell also discuss the future of HDL therapy. Brought to you by:
2012-07-09
00 min
Preventive Medicine
Emerging HDL Therapies: What’s Next on the Clinical Research Horizon
Guest: Benjamin J. Ansell, MD, FACC, FACP, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Benjamin Ansell, MD, professor of medicine and cardiology at University of Califronia at Los Angeles, CA and co-director of the Cholesterol and Hypertension Management Program at UCLA. Dr. Ansell reviews the latest trials: dal-OUTCOMES and AIM-HIGH. Dr. Ansell will address the objectives and study designs of both studies and explain why the studies were stopped early. Drs. Brown and Ansell also discuss the future of HDL therapy. Brought to you by:
2012-07-09
00 min
Lipid Luminations
Emerging HDL Therapies: What’s Next on the Clinical Research Horizon
Guest: Benjamin J. Ansell, MD, FACC, FACP, FNLA Host: Alan S. Brown, MD, FACC, FAHA, FNLA Host Dr. Alan Brown welcomes Benjamin Ansell, MD, professor of medicine and cardiology at University of Califronia at Los Angeles, CA and co-director of the Cholesterol and Hypertension Management Program at UCLA. Dr. Ansell reviews the latest trials: dal-OUTCOMES and AIM-HIGH. Dr. Ansell will address the objectives and study designs of both studies and explain why the studies were stopped early. Drs. Brown and Ansell also discuss the future of HDL therapy. Brought to you by:
2012-07-09
00 min